UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Apheresis of Deceased Donors as a New Source of Mobilized Peripheral Blood Hematopoietic Stem Cells for Transplant Tolerance

Transplantation, 2023-02, Vol.107 (2), p.504-510

2023

Volltextzugriff (PDF)

A phase II pilot study of tacrolimus/sirolimus GVHD prophylaxis for sibling donor hematopoietic stem cell transplantation using 3 conditioning regimens

Blood, 2010-02, Vol.115 (5), p.1098-1105

2010

Volltextzugriff (PDF)

Clinical outcomes and complications of recipients of HLA matched living donor kidney transplants at UCLA: A retrospective chart review

Transplantation reports, 2022-09, Vol.7 (3), p.100101, Article 100101

2022

Volltextzugriff (PDF)

Kidney Transplantation in Patients With Active Multiple Myeloma: Case Reports

Transplantation direct, 2017-08, Vol.3 (8), p.e200-e200

2017

Volltextzugriff (PDF)

MP36-11 INDUCTION OF IMMUNE TOLERANCE AFTER HAPLOIDENTICAL LIVING DONOR KIDNEY TRANSPLANT

The Journal of urology, 2022-05, Vol.207 (Supplement 5)

2022

Volltextzugriff (PDF)

Prognostic Indicators and Survival in Patients With Stage IIIB Inflammatory Breast Carcinoma After Dose-Intense Chemotherapy

Journal of clinical oncology, 2004-05, Vol.22 (10), p.1839-1848

2004

Volltextzugriff (PDF)

Chimerism and Tolerance after Combined Kidney and Hematopoietic Stem Cell Transplant

Journal of allergy and clinical immunology, 2024-02, Vol.153 (2), p.AB259

2024

Volltextzugriff (PDF)

MP52-13 DECISION-MAKING, MOTIVATIONS AND THE DONATION EXPERIENCE AMONG HLA-MATCHED LIVING KIDNEY DONORS AT UCLA

The Journal of urology, 2020-04, Vol.203 (Supplement 4)

2020

Volltextzugriff (PDF)

Immune tolerance induction through haematopoietic chimerism after kidney donation

The Lancet (British edition), 2022-08, Vol.400 (10350), p.e2-e2

2022

Volltextzugriff (PDF)

Conditional survival and cause-specific mortality after autologous hematopoietic cell transplantation for hematological malignancies

Leukemia, 2013-05, Vol.27 (5), p.1139-1145

2013

Volltextzugriff (PDF)

Second time a charm? Remobilization of peripheral blood stem cells with plerixafor in patients who previously mobilized poorly despite using plerixafor as a salvage agent

Transfusion (Philadelphia, Pa.), 2013-12, Vol.53 (12), p.3244-3250

2013

Volltextzugriff (PDF)

Reduced-Intensity Conditioning followed by Peripheral Blood Stem Cell Transplantation for Adult Patients with High-Risk Acute Lymphoblastic Leukemia

Biology of blood and marrow transplantation, 2009-11, Vol.15 (11), p.1407-1414

2009

Volltextzugriff (PDF)

Total Marrow Irradiation: A New Ablative Regimen as Part of Tandem Autologous Stem Cell Transplantation for Patients with Multiple Myeloma

Clinical cancer research, 2011-01, Vol.17 (1), p.174-182

2011

Volltextzugriff (PDF)

Comparison of Reduced-Intensity and Conventional Myeloablative Regimens for Allogeneic Transplantation in Non-Hodgkin’s Lymphoma

Biology of blood and marrow transplantation, 2006-12, Vol.12 (12), p.1326-1334

2006

Volltextzugriff (PDF)

Durable remissions with autologous stem cell transplantation for high-risk HIV-associated lymphomas

Blood, 2005-01, Vol.105 (2), p.874-878

2005

Volltextzugriff (PDF)

Continuing Medical Education Program in Transfusion

Transfusion (Philadelphia, Pa.), 2013-12, Vol.53 (12), p.3243-3243

2013

Volltextzugriff (PDF)

Allogeneic hematopoietic cell transplant for peripheral T-cell non-Hodgkin lymphoma results in long-term disease control

Leukemia & lymphoma, 2011-08, Vol.52 (8), p.1463-1473

2011

Volltextzugriff (PDF)

Extramedullary relapse following reduced intensity allogeneic hematopoietic cell transplant for adult acute myelogenous leukemia

Leukemia & lymphoma, 2013-03, Vol.54 (3), p.665-668

2013

Volltextzugriff (PDF)

A phase II trial 90 y-ibritumomab tiuxetan in combination with reduced intensity regimen of fludarabine (flu) and melphalan (mel) followed by allo-HCT in patients with refractory B-cell lymphoma

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.6545-6545

2012

Volltextzugriff (PDF)

Efficacy of radioimmunotherapy-based conditioning with high-dose chemotherapy and autologous stem cell transplantation for transformed lymphoma

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.8556-8556

2013

Volltextzugriff (PDF)

Sequential Bortezomib, Dexamethasone, and Thalidomide Maintenance Therapy after Single Autologous Peripheral Stem Cell Transplantation in Patients with Multiple Myeloma

Biology of blood and marrow transplantation, 2012-03, Vol.18 (3), p.486-492

2012

Volltextzugriff (PDF)

Conditional Survival and Cause-Specific Mortality in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation (alloHCT) for Hematologic Malignancy Over Three Decades

Blood, 2012-11, Vol.120 (21), p.606-606

2012

Volltextzugriff (PDF)

Phase I Trial of Escalated Doses of Targeted Marrow Radiation Delivered by Tomotherapy Combined with Etoposide and Cyclophosphamide; An Allogeneic HCT Preparative Regimen for Patients with Advanced Leukemia

Blood, 2012-11, Vol.120 (21), p.218-218

2012

Volltextzugriff (PDF)

Phase I-II Trial of Tandem Autologous Transplantation with Melphalan Followed by Total Marrow Irradiation Ablative Therapy in Patients with Responding or Stable Mutiple Myeloma

Blood, 2012-11, Vol.120 (21), p.3151-3151

2012

Volltextzugriff (PDF)

1 – 25 von 70

Suche als RSS-Feed

Aktive Filter

KollektionSpringerLink_现刊

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(63)
Mit Volltextzugriff
(60)

Publikationsform

Artikel
(70)

Sprache

Englisch
(70)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(26)
Life Sciences & Biomedicine
(24)
Humans
(23)
Female
(20)
Adult
(19)
Middle Aged
(19)
Hematology
(16)
Male
(16)
Aged
(14)
Transplantation
(12)
Adolescent
(10)
Biological And Medical Sciences
(10)
Medical Sciences
(10)
Disease-Free Survival
(9)
Immunology
(8)
Survival Analysis
(8)
Transplantation, Autologous
(8)
Treatment Outcome
(8)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(7)
Child
(7)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Apheresis of Deceased Donors as a New Source of Mobilized Peripheral Blood Hematopoietic Stem Cells for Transplant Tolerance

A phase II pilot study of tacrolimus/sirolimus GVHD prophylaxis for sibling donor hematopoietic stem cell transplantation using 3 conditioning regimens

Clinical outcomes and complications of recipients of HLA matched living donor kidney transplants at UCLA: A retrospective chart review

Kidney Transplantation in Patients With Active Multiple Myeloma: Case Reports

MP36-11 INDUCTION OF IMMUNE TOLERANCE AFTER HAPLOIDENTICAL LIVING DONOR KIDNEY TRANSPLANT

Prognostic Indicators and Survival in Patients With Stage IIIB Inflammatory Breast Carcinoma After Dose-Intense Chemotherapy

Chimerism and Tolerance after Combined Kidney and Hematopoietic Stem Cell Transplant

MP52-13 DECISION-MAKING, MOTIVATIONS AND THE DONATION EXPERIENCE AMONG HLA-MATCHED LIVING KIDNEY DONORS AT UCLA

Immune tolerance induction through haematopoietic chimerism after kidney donation

Conditional survival and cause-specific mortality after autologous hematopoietic cell transplantation for hematological malignancies

Second time a charm? Remobilization of peripheral blood stem cells with plerixafor in patients who previously mobilized poorly despite using plerixafor as a salvage agent

Reduced-Intensity Conditioning followed by Peripheral Blood Stem Cell Transplantation for Adult Patients with High-Risk Acute Lymphoblastic Leukemia

A phase 1/2 trial of high-dose yttrium-90-ibritumomab tiuxetan in combination with high-dose etoposide and cyclophosphamide followed by autologous stem cell transplantation in patients with poor-risk or relapsed non-Hodgkin lymphoma

Total Marrow Irradiation: A New Ablative Regimen as Part of Tandem Autologous Stem Cell Transplantation for Patients with Multiple Myeloma

Comparison of Reduced-Intensity and Conventional Myeloablative Regimens for Allogeneic Transplantation in Non-Hodgkin’s Lymphoma

Durable remissions with autologous stem cell transplantation for high-risk HIV-associated lymphomas

Continuing Medical Education Program in Transfusion

Allogeneic hematopoietic cell transplant for peripheral T-cell non-Hodgkin lymphoma results in long-term disease control

Extramedullary relapse following reduced intensity allogeneic hematopoietic cell transplant for adult acute myelogenous leukemia

A phase II trial 90 y-ibritumomab tiuxetan in combination with reduced intensity regimen of fludarabine (flu) and melphalan (mel) followed by allo-HCT in patients with refractory B-cell lymphoma

Efficacy of radioimmunotherapy-based conditioning with high-dose chemotherapy and autologous stem cell transplantation for transformed lymphoma

Sequential Bortezomib, Dexamethasone, and Thalidomide Maintenance Therapy after Single Autologous Peripheral Stem Cell Transplantation in Patients with Multiple Myeloma

Conditional Survival and Cause-Specific Mortality in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation (alloHCT) for Hematologic Malignancy Over Three Decades

Phase I Trial of Escalated Doses of Targeted Marrow Radiation Delivered by Tomotherapy Combined with Etoposide and Cyclophosphamide; An Allogeneic HCT Preparative Regimen for Patients with Advanced Leukemia

Phase I-II Trial of Tandem Autologous Transplantation with Melphalan Followed by Total Marrow Irradiation Ablative Therapy in Patients with Responding or Stable Mutiple Myeloma

Aktive Filter

Suchergebnisse filtern